Dr. Jakub Simecek

CEO at TRIMT GmbH

Speaker

Jakub´s background in chemistry (Charles University in Prague), radiopharmaceutical sciences (visiting researcher at University of Helsinki and at MSKCC, NY) and development of targeted radiolabelled conjugates, their preclinical evaluation and transfer to first-in-human studies (doctoral degree at TU München) resulted in different positions in radiopharmaceutical industry after leaving the academia. He led various technical (small scale GMP production) and radiopharmaceutical projects toward establishing novel radiodiagnostic and radiotherapeutic applications (innovative Ga-68, Lu-177 and Ac-225 based APIs). Since 2014, he has been active in business with radiopharmaceuticals across the globe. Jakub serves as CEO of TRIMT GmbH and cares also for the business development.